Sign in
Download Opera News App

PARP

'Angelina Jolie gene' targeted by new cancer drug breakthrough

British researchers have identified a new class of targeted cancer drugs A new type of drug could treat a range of cancers triggered by the 'Angelina Jolie gene,' according to a new study. British researchers have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes.

hertfordshiremercury.co.uk ,  22h 32
'Angelina Jolie gene' targeted by new cancer drug breakthrough

Drugs used against ovarian cancer offer hope in tackling other forms of disease

A class of drugs used against ovarian and breast cancers may also be effective for other forms of the disease which currently have limited treatment options, according to scientists.A new study suggests these medicines, known as PARP inhibitors, are able to kill cancer cells which harbour a defect in a gene known as PBRM1 by destroying their DNA defences.

gazetteandherald.co.uk ,  1m 0
Drugs used against ovarian cancer offer hope in tackling other forms of disease

Precision medicine combination to be offered to more ovarian cancer patients

An ovarian cancer drug developed thanks to research by Professor Steve Jackson and his team at the University of Cambridge can now be used in a new combination that could help 1,100 women in England.

cambridgeindependent.co.uk ,  2m 0
Precision medicine combination to be offered to more ovarian cancer patients